Laboratorio Farmaceutico Valuation Multiples

Discover Laboratorio Farmaceutico's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Ecomiam, Wing Yip Food Holdings, Australian Dairy, Civita Group and more.

Laboratorio Farmaceutico Overview

About Laboratorio Farmaceutico

Laboratorio Farmaceutico Erfo SpA operates in the nutraceutical sector. The company specializes in formulating and producing food supplements and natural medicines in different forms such as liquids, powders, granules, tablets, and soft gels. Geographically, the company generates a majority of its revenue from Italy followed by Spain, France, Belgium, and other countries.


Founded

2013

HQ

Italy

Employees

33

Website

erfo.it

Financials (LTM)

Revenue: $11M
EBITDA: $3M

EV

$12M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Laboratorio Farmaceutico Financials

Laboratorio Farmaceutico reported last 12-month revenue of $11M and EBITDA of $3M.

In the same LTM period, Laboratorio Farmaceutico generated $3M in EBITDA and $652K in net income.


Laboratorio Farmaceutico P&L

In the most recent fiscal year, Laboratorio Farmaceutico reported revenue of $11M and EBITDA of $2M.

Laboratorio Farmaceutico is profitable as of last fiscal year, with gross margin of 69%, EBITDA margin of 21%, and net margin of 4%.

See analyst estimates for Laboratorio Farmaceutico
LTMLast FY202320242025202620272028
Revenue$11M$11M$7M$7M$11M
Gross Profit-$8M$5M$5M$8M
Gross Margin-69%72%72%70%
EBITDA$3M$2M$2M$1M$2M
EBITDA Margin22%21%26%21%21%
EBIT Margin13%12%15%10%12%
Net Profit$652K$472K$634K$420K$437K
Net Margin6%4%9%6%4%
Net Debt-$338K---

Financial data powered by Morningstar, Inc.

Laboratorio Farmaceutico Stock Performance

Laboratorio Farmaceutico has current market cap of $11M, and enterprise value of $12M.

Market Cap Evolution


Laboratorio Farmaceutico's stock price is $1.35.

Laboratorio Farmaceutico share price increased by 0.2% in the last 30 days, and decreased by 8.2% in the last year.

Laboratorio Farmaceutico has an EPS (earnings per share) of $0.06.

See more trading valuation data for Laboratorio Farmaceutico
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$12M$11M-1.7%0.2%0.5%-8.2%$0.06

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Laboratorio Farmaceutico Valuation Multiples

Laboratorio Farmaceutico trades at 1.0x EV/Revenue multiple, and 4.7x EV/EBITDA.

See NTM and 2027E valuation multiples for Laboratorio Farmaceutico

Laboratorio Farmaceutico Financial Valuation Multiples

As of July 19, 2026, Laboratorio Farmaceutico has market cap of $11M and EV of $12M.

Laboratorio Farmaceutico has a P/E ratio of 17.5x.

LTMLast FY202320242025202620272028
EV/Revenue1.0x1.1x1.7x1.7x1.1x
EV/EBITDA4.7x5.0x6.6x8.3x5.1x
EV/EBIT8.0x9.0x11.2x17.1x9.0x
EV/Gross Profit-1.5x2.4x2.4x1.5x
P/E17.5x24.1x18.0x27.1x26.1x
EV/FCF73.9x(6.2x)(69.1x)14.2x(6.2x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Laboratorio Farmaceutico Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Laboratorio Farmaceutico Margins & Growth Rates

Laboratorio Farmaceutico grew revenue by 5% and EBITDA by 11% in the last fiscal year.

In the most recent fiscal year, Laboratorio Farmaceutico reported gross margin of 69%, EBITDA margin of 21%, and net margin of 4%.

See estimated margins and future growth rates for Laboratorio Farmaceutico

Laboratorio Farmaceutico Margins

Last FY202420252026202720282029
Gross Margin69%72%70%-
EBITDA Margin21%21%21%23%
EBIT Margin12%10%12%15%
Net Margin4%6%4%7%
FCF Margin(17%)12%(17%)17%

Laboratorio Farmaceutico Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth5%2%60%6%
Gross Profit Growth-2%54%-
EBITDA Growth11%(21%)62%14%
EBIT Growth31%(35%)91%31%
Net Profit Growth70%(34%)4%83%
FCF Growth(203%)(588%)(328%)(203%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Laboratorio Farmaceutico Operational KPIs

Laboratorio Farmaceutico's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.2M for the same period.

Laboratorio Farmaceutico's Rule of 40 is 28% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Laboratorio Farmaceutico's Rule of X is 37% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Laboratorio Farmaceutico
LTMLast FY202320242025202620272028
Rule of 4030%28%---
Bessemer Rule of X41%37%---
Revenue per Employee-$0.3M---
Opex per Employee-$0.2M---
Opex to Revenue-57%56%62%58%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Laboratorio Farmaceutico Competitors

Laboratorio Farmaceutico competitors include Ecomiam, Wing Yip Food Holdings, Australian Dairy, Civita Group, Jatcorp, Fountain, Kalve Coffee, Empresa Agricola Sintuco, Nuchev and Willamette Valley.

Most Laboratorio Farmaceutico public comparables operate across Food & Beverages.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Ecomiam0.3x0.3x(4.5x)(8.2x)
Wing Yip Food Holdings0.1x-0.6x-
Australian Dairy2.0x-(3.3x)-
Civita Group1.7x-19.7x-
Jatcorp0.5x-(3.0x)-
Fountain0.4x-4.0x-
Kalve Coffee1.4x-47.9x-
Empresa Agricola Sintuco----

This data is available for Pro users. Sign up to see all Laboratorio Farmaceutico competitors and their valuation data.

Start Free Trial

Acquisitions by Laboratorio Farmaceutico

Laboratorio Farmaceutico has acquired 1 company to date.

Last acquisition by Laboratorio Farmaceutico was on December 30th 2024. Laboratorio Farmaceutico acquired Fit And Go for $5M (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by Laboratorio Farmaceutico

Fit And Go
Description
Milan-based Fit And Go operates a chain of 15 EMS gyms across Italy offering 20-minute electro-muscle stimulation sessions combined with bodyweight circuits and personal training. Each studio features Miha Bodytec suits delivering up to 30,000 muscle contractions per workout, certified by TÜV for safety. Founded in 2017, the franchise model expands to Rome and Turin locations with memberships starting at group classes tracked via proprietary app.
HQ CountryItaly
HQ City
Rome
Deal Date30 Dec 2024
Valuation$5M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Laboratorio Farmaceutico acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Laboratorio Farmaceutico

When was Laboratorio Farmaceutico founded?Laboratorio Farmaceutico was founded in 2013.
Where is Laboratorio Farmaceutico headquartered?Laboratorio Farmaceutico is headquartered in Italy.
How many employees does Laboratorio Farmaceutico have?As of today, Laboratorio Farmaceutico has over 33 employees.
Is Laboratorio Farmaceutico publicly listed?Yes, Laboratorio Farmaceutico is a public company listed on Borsa Italiana.
What is the stock symbol of Laboratorio Farmaceutico?Laboratorio Farmaceutico trades under ERFO ticker.
When did Laboratorio Farmaceutico go public?Laboratorio Farmaceutico went public in 2022.
Who are competitors of Laboratorio Farmaceutico?Laboratorio Farmaceutico main competitors include Ecomiam, Wing Yip Food Holdings, Australian Dairy, Civita Group, Jatcorp, Fountain, Kalve Coffee, Empresa Agricola Sintuco, Nuchev, Willamette Valley.
What is the current market cap of Laboratorio Farmaceutico?Laboratorio Farmaceutico's current market cap is $11M.
What is the current revenue of Laboratorio Farmaceutico?Laboratorio Farmaceutico's last 12 months revenue is $11M.
What is the current revenue growth of Laboratorio Farmaceutico?Laboratorio Farmaceutico revenue growth (NTM/LTM) is 8%.
What is the current EV/Revenue multiple of Laboratorio Farmaceutico?Current revenue multiple of Laboratorio Farmaceutico is 1.0x.
What is the current EBITDA of Laboratorio Farmaceutico?Laboratorio Farmaceutico's last 12 months EBITDA is $3M.
What is Laboratorio Farmaceutico's EBITDA margin?Laboratorio Farmaceutico's last 12 months EBITDA margin is 22%.
What is the current EV/EBITDA multiple of Laboratorio Farmaceutico?Current EBITDA multiple of Laboratorio Farmaceutico is 4.7x.
What is the current FCF of Laboratorio Farmaceutico?Laboratorio Farmaceutico's last 12 months FCF is $159K.
What is Laboratorio Farmaceutico's FCF margin?Laboratorio Farmaceutico's last 12 months FCF margin is 1%.
What is the current EV/FCF multiple of Laboratorio Farmaceutico?Current FCF multiple of Laboratorio Farmaceutico is 73.9x.
How many companies Laboratorio Farmaceutico has acquired to date?As of July 2026, Laboratorio Farmaceutico has acquired 1 company.
What was the largest acquisition by Laboratorio Farmaceutico?$5M acquisition of Fit And Go on 30th December 2024 was the largest M&A Laboratorio Farmaceutico has done to date.
What companies Laboratorio Farmaceutico acquired?Laboratorio Farmaceutico acquired Fit And Go.
In how many companies Laboratorio Farmaceutico has invested to date?Laboratorio Farmaceutico hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Laboratorio Farmaceutico

Lists including Laboratorio Farmaceutico

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial